Shares of Thermo Fisher Scientific Inc. TMO slipped 2.13% to $427.50 Thursday, on what proved to be an all-around mixed ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $629.44, with a ...

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its Advanced ...

Analysts on Wall Street project that Thermo Fisher Scientific (TMO) will announce quarterly earnings of $5.10 per share in its forthcoming report, representing a decline of 0.2% year over year.

Thermo Fisher Scientific shows strong fundamentals, consistent earnings growth, and solid financial health, making it a ...

A new collaboration facility, opened by Thermo Fisher Scientific, will work to make cell therapy developers’ research more accessible and optimized.

LifeSciKY has announced Thermo Fisher Scientific Inc. will become the founding sponsor of the Covington-based nonprofit lab ...

Bernstein lowered the firm’s price target on Thermo Fisher (TMO) to $585 from $690 and keeps an Outperform rating on the shares. With tariffs, ...

A significant trading signal occurred for shares of Thermo Fisher Scientific at $444.92, after which TMO rose up to 1.3%.

Baird lowered the firm’s price target on Thermo Fisher (TMO) to $603 from $660 and keeps an Outperform rating on the shares. The firm updated ...

Thermo Fisher Scientific Inc. closed 30.22% below its 52-week high of $627.88, which the company reached on September 10th.